Flumed (Fluconazole)

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flumed (Fluconazole)

Property Description
Active ingredient Fluconazole
Form Capsules, Tablets, Oral Suspension, IV Injection
Pharmacological class Antifungal Agent (Triazole Derivative)
Origin Synthetic Drug

Flumed is a prescription-only medicine whose active ingredient, Fluconazole, is classified as a systemic antifungal agent and belongs to the Triazole derivative family. It is a synthetic drug, meaning its structure is chemically engineered to target fungal organisms specifically. Fluconazole is widely recognized in clinical practice as a reliable agent for addressing systemic fungal infections.

What Type of Medicine is Flumed (Fluconazole)?

As a triazole derivative, Fluconazole's core function is to provide fungistatic control, limiting the ability of fungal cells to grow and reproduce throughout the body. Fluconazole functions as an agent used to prevent the formation of the fungal cell membrane. This confirms that the medicine's primary action is dedicated to stopping fungal proliferation at the cellular level. Fluconazole has become a standard therapeutic agent due to its established track record and its capacity for high oral absorption, a key differentiating factor that sets it apart from some older systemic antifungal agents.

Composition, Forms, and General Purpose

Fluconazole is typically a single-ingredient product, available globally under various brands. It is provided in diverse dosage forms, including oral forms such as capsules, tablets, and oral suspension, as well as a sterile solution for intravenous injection (IV). The availability of these forms supports different needs in patient care, offering both oral and intravenous routes of administration. Fluconazole is characterized by its ability to be absorbed well orally and reach various sites of infection. This flexibility in administration is a critical feature, particularly when treating individuals who cannot take oral medication. Its general therapeutic purpose is to control the spread of the fungal infection by crippling the structural integrity of the fungal cell.

What side effects are possible with Flumed (Fluconazole)?

Possible side effects and safety information

The official safety profile for Fluconazole, as documented by regulatory authorities, classifies potential adverse reactions by frequency and the body system affected. These classifications ensure a clear communication of the established risks.


Key Adverse Reaction Classifications

Common Adverse Reactions: Adverse reactions designated as common (occurring in up to 1 in 10 patients) primarily include Nervous System disorders such as headache, and Gastrointestinal disorders including nausea, vomiting, abdominal pain, and diarrhea. Elevations in liver function tests (increased ALT, AST, and ALP) are also commonly observed hepatobiliary effects.

System-Organ Classes Involved: Adverse events are formally grouped into categories such as Gastrointestinal disorders, Nervous system disorders, Hepatobiliary disorders, Skin and subcutaneous tissue disorders (e.g., rash), and Cardiac disorders.


Serious Safety Considerations

Official labeling explicitly highlights Rare but serious adverse reactions. These include the potential for Severe Hepatic Toxicity, such as hepatic failure, which is a critical, though infrequent, event. Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome, are also documented as rare, potentially life-threatening complications. The drug is associated with a risk of QT interval prolongation and the rare ventricular arrhythmia Torsade de pointes, which are serious cardiovascular safety concerns.

Safety-Related Restrictions: Fluconazole is formally Contraindicated in individuals with known hypersensitivity to the drug or other triazole antifungals. It is also restricted from co-administration with certain other medications known to prolong the QT interval due to the established risk of serious cardiac events.

Population-Specific Notes: Specific safety statements address patients with renal impairment, where dosage adjustments may be necessary due to the drug’s clearance profile. Caution is warranted in patients with pre-existing hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Fluconazole overexposure focuses on documented signs of Central Nervous System (CNS) toxicity.


Documented Manifestations and Emergency Triggers

Overdose has been reported to involve distinct psychiatric and neurological symptoms. The documented manifestations include hallucination (seeing or hearing things that do not exist) and paranoid behavior (such as fearfulness and suspiciousness).

Immediate medical attention is required for severe outcomes of overexposure. Regulators mandate contacting emergency services (such as 911 or the local emergency number) or a Poison Control center immediately if the affected individual has collapsed, had a seizure, has trouble breathing, or cannot be awakened.


Supportive Management and Drug Elimination

In the event of overexposure, management is based on established protocols for toxicity. No specific antidote is known to pharmacologically reverse the effects of the overdose. Therefore, treatment involves instituting symptomatic treatment with supportive measures to manage any adverse clinical presentation. Due to the high renal excretion of the drug, procedures like gastric lavage may be considered if clinically indicated. Furthermore, a session of hemodialysis may be utilized as a measure to significantly enhance the removal of the drug from the body and reduce high plasma concentrations.

Therapeutic Uses of Flumed (Fluconazole)

What Flumed (Fluconazole) Treats: Main Uses and Benefits

Flumed (Fluconazole) is a prescription medication utilized in a number of therapeutic settings to address fungal and yeast infections. Its use is reserved for conditions responsive to this class of antifungal therapy.

The medication is employed to manage various types of candidiasis, which are infections caused by Candida yeast. These include localized infections such as vaginal candidiasis (yeast infection) and mucosal candidiasis affecting the mouth (oropharyngeal candidiasis or thrush) and the esophagus (esophageal candidiasis).

Flumed is also indicated for managing more widespread and serious systemic fungal infections, including candidemia and other forms of disseminated candidiasis. A key use includes the management of cryptococcal meningitis, a fungal infection impacting the brain and spinal cord lining. Furthermore, the medication may be administered to certain at-risk patients to help reduce the occurrence of candidiasis, such as individuals undergoing bone marrow transplantation who are receiving chemotherapy or radiation therapy. It helps to control the spread of these specific fungal pathogens.


Quick Facts

  • Therapeutic Domain: Addresses infections caused by Candida yeast (candidiasis) and Cryptococcus fungi.
  • Key Conditions: Used to manage vaginal candidiasis, thrush, esophageal candidiasis, systemic candidal infections, and cryptococcal meningitis.
  • Preventative Use: May be employed to reduce the incidence of candidiasis in specific, high-risk patient populations.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Official Eligibility Profile for Flumed (Fluconazole)

This section outlines the population eligibility rules for Fluconazole as mandated by government regulatory bodies.


Absolute Contraindications

Fluconazole use is formally prohibited in patients with known hypersensitivity to Fluconazole, any of its excipients, or other azole antifungals. It is also contraindicated if co-administered with specific medications known to prolong the QT interval and metabolized via the CYP3A4 enzyme (e.g., pimozide, quinidine). Chronic, high-dose use (ge 400 mg/day) during the first trimester of pregnancy is also generally contraindicated due to the risk of congenital malformations.


Eligibility Limitations and Restricted Use ️

Population Group Restriction Type
Renal Impairment Requires mandatory dose adjustment when creatinine clearance ( CrCl) is le 50 mL/min.
Liver Dysfunction Must be administered with caution and requires close monitoring for hepatic injury.
Cardiac Risk Factors Use requires caution in patients with conditions like pre-existing arrhythmias or uncorrected low electrolyte levels.
Infants ( < 6 months) Efficacy and safety are not established for all systemic indications.
Pediatric Patients ( < 16 years) Not recommended for the specific indication of vaginal candidiasis.

Fluconazole use in breastfeeding women is often discouraged, although a single, low dose is commonly considered acceptable with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented drug-drug and drug-substance interactions for Fluconazole, based strictly on government regulatory documents.

Fluconazole is known to be a potent inhibitor of cytochrome P450 (CYP) isoenzyme 2C9 and a moderate inhibitor of CYP3A4 and CYP2C19. This inhibitory action increases the plasma concentrations and systemic exposure (AUC) of many co-administered medicinal products that are metabolized by these enzymes.

Contraindicated Combinations

Co-administration with specific medications is strictly forbidden due to the high risk of serious adverse effects, primarily cardiac. These include other medicines known to prolong the QT interval, such as Cisapride, Astemizole, Pimozide, Quinidine, and Erythromycin (and Terfenadine at doses ge 400 mg/day). These combinations significantly increase the risk of Torsades de Pointes.

Clinically Significant Pharmacokinetic Interactions

Interacting Product Category Effect on Partner Drug Management Constraint
CYP3A4/2C9 Substrates (e.g., Warfarin, Immunosuppressants) Increased exposure and plasma concentrations. Requires close monitoring and typically dose adjustment of the partner drug.
Rifampicin (CYP Inducer) Decreased Fluconazole exposure (AUC decreased by 25%). Requires monitoring for decreased Fluconazole effectiveness.
Hydrochlorothiazide (Diuretic) Increased Fluconazole exposure (AUC increased by 40%). Requires monitoring for potential Fluconazole toxicity.

Other Constraints

Studies documented that food, antacids (e.g., Maalox), and total body irradiation do not significantly impair the absorption of Fluconazole, meaning no specific timing separation is required for these common substances.

Mechanism of Action

Mechanism of Action: How Flumed (Fluconazole) Works


Flumed (Fluconazole) acts as a highly selective non-competitive inhibitor of the fungal enzyme Cytochrome P450 14alpha-lanosterol demethylase (CYP51). This enzyme is crucial for the ergosterol biosynthesis pathway in fungal cells. The drug molecule binds directly to the heme iron of the CYP51 enzyme, effectively blocking its catalytic function.

This specific molecular interaction initiates an intracellular cascade: the necessary conversion of lanosterol into ergosterol is prevented, leading to ergosterol depletion. Concurrently, abnormal, toxic 14alpha-methylated sterols accumulate within the fungal cell membrane. The resulting structural and functional disruption compromises the integrity of the cell membrane, increases permeability, and causes a loss of cellular homeostasis, producing a fungistatic or fungicidal effect on the fungal organism.

Dosage and Administration Information

How to Use Flumed (Fluconazole)

The administration of Fluconazole is governed by official instructions detailing the route, dosage, frequency, and necessary adjustments for specific populations. The medicine is approved for both oral intake, via capsules, tablets, or reconstituted suspension, and administration by intravenous (IV) infusion. The daily dose is the same regardless of the chosen administration route.

Dosing and Schedule Principles

Treatment regimens typically begin with a loading dose on the first day, often equal to twice the daily maintenance dose, to ensure effective plasma concentrations are reached rapidly. The subsequent maintenance dose is usually taken once daily. While some acute infections require a single 150 mg oral dose, deep-seated or recurrent conditions require longer courses. For example, maintenance therapy to prevent relapse of cryptococcal meningitis may continue for an indefinite duration. Oral forms may be taken with or without food for convenience.

Administration Requirements and Adjustments

Specific procedural rules must be followed for administration. Intravenous infusion must be delivered slowly, at a rate not exceeding 10 mL/minute. Administration should occur at the same time each day for consistency.

Dosing adjustments are officially mandated for certain patient groups. Individuals with impaired renal function (creatinine clearance le 50 mL/min) require a 50% reduction in the standard maintenance dose. For pediatric patients, the dosage is calculated based on body weight (mg/kg), and the maximum adult dose must not be exceeded.

Recent Clinical Evidence

Research Evidence / Overview of Studies

A. Research Focus

Preclinical and early clinical studies have explored how the fluconazole compound interacts with fungal biological systems. Clinical data has also assessed the compound's profile, including its use in specific patient populations, such as those with mild liver impairment.


B. Findings on Symptom Evaluation

Research has explored the use of this compound for managing symptoms associated with various fungal infections, including those affecting the mouth, throat, and vagina.

1. Clinical Trials (Resolution Rates)

In certain randomized trials, participants who received the fluconazole compound reported resolution rates of their targeted infections that differed from those observed in the placebo group. Findings included data on symptom clearance rates over a typical treatment period.

2. Recurrence Studies

Clinical research has evaluated outcomes related to preventing the recurrence of certain infections following initial successful treatment. Research assessed data points such as the time to recurrence and the rates of subsequent symptomatic episodes.


C. Tolerability and Data Collection

Data regarding the tolerability of the compound was collected from study participants across various trials. The most frequently reported adverse events in clinical data included headache, nausea, and abdominal discomfort. These findings are described in detail in the full study reports.


D. Combination Studies

Research data has examined the results when fluconazole was administered alongside other antifungal agents. These studies compared the measurable health outcomes and tolerability profiles in the combination group versus the group receiving a single agent alone.

Frequently Asked Questions (FAQ)

Common questions about Flumed (Fluconazole) (FAQ)

Q: Does Flumed only treat Candida infections, or can it be used for other types of fungus too?

A: Regulatory information indicates that Flumed is used for specific infections beyond those caused by Candida species. The medicine is also approved for the treatment of severe fungal conditions like Cryptococcal meningitis and Coccidioidomycosis, demonstrating its activity against a range of fungal organisms.

Q: Can Flumed treat cold and flu symptoms?

A: Official labeling indicates that Flumed is classified solely as a systemic antifungal agent. Its therapeutic purpose is dedicated exclusively to the treatment and prevention of fungal infections, and it is not indicated for viral illnesses like the common cold or flu.

Q: Is Flumed used for common skin infections like ringworm or athlete's foot?

A: Official indications include the treatment of certain skin and nail infections when systemic therapy is considered necessary. This includes conditions such as Tinea pedis (athlete's foot), Tinea corporis (ringworm), and other forms of Dermatomycosis.

Q: Does Flumed contain any common allergens like lactose or sucrose?

A: The official excipient list for the tablet and capsule forms of Fluconazole generally indicates the presence of lactose monohydrate. Official documentation notes that patients with hereditary intolerances to galactose or lactose may need to consider alternate formulations.

Q: What are the indicators that a patient should seek a follow-up regarding the medication's effect?

A: Regulatory safety information highlights the need to monitor for signs of serious adverse reactions, especially those involving the liver and skin. Indicators of potential liver issues can include jaundice (yellowing of the skin or eyes), dark urine, or unusual, persistent fatigue.

Q: How long does Flumed typically remain in the body after the last dose is taken?

A: Fluconazole is known to have a long elimination half-life, which is the time it takes for half of the drug to be cleared from the body. Official pharmacokinetic data indicates the elimination half-life is typically around 30 hours, meaning the drug remains present in the system for several days after the last dose.

Q: Is it possible to experience dizziness or lightheadedness when taking Flumed?

A: Official safety documentation reports that dizziness is a recognized adverse reaction associated with the use of Fluconazole. It is generally categorized as a nervous system disorder.

Q: Has Flumed been linked to changes in the ability to taste food?

A: Studies and official information indicate that a change in the ability to taste, often described as 'taste perversion' or 'dysgeusia,' has been reported as an uncommon side effect of the medicine.

Q: Is there any general caution about driving or operating machinery after taking Flumed?

A: Official product information advises caution regarding driving or operating complex machinery due to the potential for the medicine to impair cognitive or motor abilities, stemming from side effects such as dizziness or, rarely, seizures.

Q: Are there any known long-term side effects associated with taking Flumed over an extended period?

A: When the medicine is taken at high doses or over long periods, official safety data indicates that adverse effects like hair loss (alopecia) and certain liver or blood-related laboratory abnormalities have been reported more frequently.

Q: Does Flumed interact with common over-the-counter pain relievers like ibuprofen or NSAIDs?

A: Official drug interaction data indicates that Fluconazole is documented to interact with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen. This interaction can increase the systemic exposure (plasma concentrations) of the NSAID.

Q: Can Flumed affect the effectiveness of birth control pills or other hormonal contraceptives?

A: A formal pharmacokinetic interaction is documented in official labeling. Fluconazole can increase the systemic concentrations of certain components of oral contraceptives, such as ethinyl estradiol and levonorgestrel.

Q: Can Flumed interact with common herbal supplements or dietary products?

A: Official cautions indicate that Fluconazole acts as a liver enzyme inhibitor, meaning it has the potential to interact with many other products, including herbal remedies or supplements. The safety of all combinations is not always confirmed, and caution is generally warranted.

Q: How long does the drug-metabolism inhibiting effect of Flumed last after stopping the medication?

A: The inhibitory effect on liver enzymes (CYP2C9/3A4) decreases as the drug is eliminated from the body. Because Fluconazole has a long elimination half-life (around 30 hours), the enzyme inhibition may persist for several days after the final dose.

Q: Is Flumed appropriate for patients who have weakened immune systems?

A: Official labeling indicates that Fluconazole is formally indicated for the prophylaxis (prevention) of fungal infections in certain patient groups with weakened immune systems. This includes patients experiencing prolonged neutropenia or individuals with HIV/AIDS.

Q: Can people with hereditary conditions like lactose intolerance safely take all forms of Flumed?

A: The capsule and tablet forms of Fluconazole often contain lactose as an excipient. Regulatory documents note that patients with rare hereditary problems like lactose intolerance may need to use a different formulation, such as the oral suspension.

Q: Is Flumed a standard treatment option for people with certain types of fungal meningitis?

A: Official indications include the use of Fluconazole for the treatment of Cryptococcal meningitis. It is also approved for long-term maintenance therapy to help prevent the relapse of this severe infection.

Q: Why is Flumed sometimes used to prevent fungal infections instead of just treating them?

A: Fluconazole is used preventatively (prophylaxis) because of its pharmacokinetic profile. Its high oral absorption and long half-life allow for consistent daily or weekly dosing, which helps maintain effective blood concentrations to prevent the recurrence of susceptible infections.

Q: If symptoms return shortly after the initial dose, what is the generally accepted reason?

A: Official product safety information addresses the potential for infections to return, stating it may be a sign of relapse of the original infection. It is also possible, though rare, that the returning infection is due to the development of drug resistance or a superinfection with a less susceptible organism.

Q: What are the signs of a rare, serious side effect related to liver health while taking Flumed?

A: The medicine carries a documented risk of severe hepatic toxicity. Signs of this rare but serious adverse reaction can include jaundice (yellowing of the skin or eyes), dark urine, or unusual, unexplained fatigue.

Q: Is there a known interaction between Flumed and certain heart medications?

A: Official regulatory documents mandate that Flumed is strictly contraindicated (forbidden) for co-administration with several medicines known to prolong the QT interval, such as Quinidine, due to the serious risk of abnormal heart rhythms.

Q: Does taking Flumed with food change how it might interact with other medicines?

A: Regulatory studies have shown that taking Fluconazole with food does not significantly affect its systemic absorption. Therefore, the presence of food is not a factor that dictates the timing of the dose relative to other interacting medicines.

Q: Is Flumed generally suitable for use in children under the age of 12 for fungal infections?

A: Official labeling indicates that Fluconazole is indicated for the treatment of various fungal infections in the pediatric population. Dosing and safety are established for children as young as 6 months for certain uses, with the dosage calculated based on body weight.

Q: Does Flumed have any contraindications for people with low levels of potassium or magnesium?

A: Low levels of potassium ( hypokalemia) or magnesium are not an absolute contraindication, but they require caution as mandated by official warnings. This is because these electrolyte abnormalities can increase the already-established risk of serious heart rhythm changes (QT prolongation).

Q: What have regulatory bodies stated about the possible risk of miscarriage when taking a single, low dose of Flumed in early pregnancy?

A: Official labeling contraindicates the chronic, high-dose (ge 400 mg/day) use during the first trimester due to a risk of congenital malformations. The potential risks associated with a single, low dose are generally considered to require individual risk-benefit assessment by the prescribing physician.

How should Flumed (Fluconazole) be stored and disposed of?

Storage and Disposal of Flumed (Fluconazole)

The storage requirements for Flumed depend on the formulation, as specified in regulatory labeling.


Storage Conditions

Formulation Required Temperature Additional Protection
Tablets/Capsules & Dry Powder Below 30 C (86 F) Keep away from light and moisture
Reconstituted Oral Suspension Between 5 C (41 F) and 30 C (86 F) Protect from freezing

Stability and Safety

Regulatory documents mandate that the reconstituted oral suspension must be discarded after 14 days from mixing. All fluconazole products must be kept out of the reach of children and pets and stored in a secure location.

Disposal Instructions

Unused or expired medication must be disposed of in accordance with all local and national regulations. To prevent environmental contamination, it is required to avoid release to the environment, meaning the product should not be flushed down a toilet or poured down a drain unless a specific method is instructed.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flumed (Fluconazole) found in:

A-Z Index: